Cargando…

Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV

Non-invasive biomarkers that predict HIV remission after antiretroviral therapy (ART) interruption are urgently needed. Such biomarkers can improve the safety of analytic treatment interruption (ATI) and provide mechanistic insights into the host pathways involved in post-ART HIV control. Here we re...

Descripción completa

Detalles Bibliográficos
Autores principales: Giron, Leila B., Palmer, Clovis S., Liu, Qin, Yin, Xiangfan, Papasavvas, Emmanouil, Sharaf, Radwa, Etemad, Behzad, Damra, Mohammad, Goldman, Aaron R., Tang, Hsin-Yao, Johnston, Rowena, Mounzer, Karam, Kostman, Jay R., Tebas, Pablo, Landay, Alan, Montaner, Luis J., Jacobson, Jeffrey M., Li, Jonathan Z., Abdel-Mohsen, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241829/
https://www.ncbi.nlm.nih.gov/pubmed/34188039
http://dx.doi.org/10.1038/s41467-021-24077-w
_version_ 1783715497824485376
author Giron, Leila B.
Palmer, Clovis S.
Liu, Qin
Yin, Xiangfan
Papasavvas, Emmanouil
Sharaf, Radwa
Etemad, Behzad
Damra, Mohammad
Goldman, Aaron R.
Tang, Hsin-Yao
Johnston, Rowena
Mounzer, Karam
Kostman, Jay R.
Tebas, Pablo
Landay, Alan
Montaner, Luis J.
Jacobson, Jeffrey M.
Li, Jonathan Z.
Abdel-Mohsen, Mohamed
author_facet Giron, Leila B.
Palmer, Clovis S.
Liu, Qin
Yin, Xiangfan
Papasavvas, Emmanouil
Sharaf, Radwa
Etemad, Behzad
Damra, Mohammad
Goldman, Aaron R.
Tang, Hsin-Yao
Johnston, Rowena
Mounzer, Karam
Kostman, Jay R.
Tebas, Pablo
Landay, Alan
Montaner, Luis J.
Jacobson, Jeffrey M.
Li, Jonathan Z.
Abdel-Mohsen, Mohamed
author_sort Giron, Leila B.
collection PubMed
description Non-invasive biomarkers that predict HIV remission after antiretroviral therapy (ART) interruption are urgently needed. Such biomarkers can improve the safety of analytic treatment interruption (ATI) and provide mechanistic insights into the host pathways involved in post-ART HIV control. Here we report plasma glycomic and metabolic signatures of time-to-viral-rebound and probability-of-viral-remission using samples from two independent cohorts. These samples include a large number of post-treatment controllers, a rare population demonstrating sustained virologic suppression after ART-cessation. These signatures remain significant after adjusting for key demographic and clinical confounders. We also report mechanistic links between some of these biomarkers and HIV latency reactivation and/or myeloid inflammation in vitro. Finally, machine learning algorithms, based on selected sets of these biomarkers, predict time-to-viral-rebound with 74% capacity and probability-of-viral-remission with 97.5% capacity. In summary, we report non-invasive plasma biomarkers, with potential functional significance, that predict both the duration and probability of HIV remission after treatment interruption.
format Online
Article
Text
id pubmed-8241829
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82418292021-07-20 Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV Giron, Leila B. Palmer, Clovis S. Liu, Qin Yin, Xiangfan Papasavvas, Emmanouil Sharaf, Radwa Etemad, Behzad Damra, Mohammad Goldman, Aaron R. Tang, Hsin-Yao Johnston, Rowena Mounzer, Karam Kostman, Jay R. Tebas, Pablo Landay, Alan Montaner, Luis J. Jacobson, Jeffrey M. Li, Jonathan Z. Abdel-Mohsen, Mohamed Nat Commun Article Non-invasive biomarkers that predict HIV remission after antiretroviral therapy (ART) interruption are urgently needed. Such biomarkers can improve the safety of analytic treatment interruption (ATI) and provide mechanistic insights into the host pathways involved in post-ART HIV control. Here we report plasma glycomic and metabolic signatures of time-to-viral-rebound and probability-of-viral-remission using samples from two independent cohorts. These samples include a large number of post-treatment controllers, a rare population demonstrating sustained virologic suppression after ART-cessation. These signatures remain significant after adjusting for key demographic and clinical confounders. We also report mechanistic links between some of these biomarkers and HIV latency reactivation and/or myeloid inflammation in vitro. Finally, machine learning algorithms, based on selected sets of these biomarkers, predict time-to-viral-rebound with 74% capacity and probability-of-viral-remission with 97.5% capacity. In summary, we report non-invasive plasma biomarkers, with potential functional significance, that predict both the duration and probability of HIV remission after treatment interruption. Nature Publishing Group UK 2021-06-29 /pmc/articles/PMC8241829/ /pubmed/34188039 http://dx.doi.org/10.1038/s41467-021-24077-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Giron, Leila B.
Palmer, Clovis S.
Liu, Qin
Yin, Xiangfan
Papasavvas, Emmanouil
Sharaf, Radwa
Etemad, Behzad
Damra, Mohammad
Goldman, Aaron R.
Tang, Hsin-Yao
Johnston, Rowena
Mounzer, Karam
Kostman, Jay R.
Tebas, Pablo
Landay, Alan
Montaner, Luis J.
Jacobson, Jeffrey M.
Li, Jonathan Z.
Abdel-Mohsen, Mohamed
Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV
title Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV
title_full Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV
title_fullStr Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV
title_full_unstemmed Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV
title_short Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV
title_sort non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of hiv
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241829/
https://www.ncbi.nlm.nih.gov/pubmed/34188039
http://dx.doi.org/10.1038/s41467-021-24077-w
work_keys_str_mv AT gironleilab noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT palmercloviss noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT liuqin noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT yinxiangfan noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT papasavvasemmanouil noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT sharafradwa noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT etemadbehzad noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT damramohammad noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT goldmanaaronr noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT tanghsinyao noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT johnstonrowena noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT mounzerkaram noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT kostmanjayr noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT tebaspablo noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT landayalan noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT montanerluisj noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT jacobsonjeffreym noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT lijonathanz noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv
AT abdelmohsenmohamed noninvasiveplasmaglycomicandmetabolicbiomarkersofposttreatmentcontrolofhiv